Search
for
Sort by
Research 871–900 of 1000+
- 전립선 비대유도 쥐의 전립선 조직에서 울금 급여에 따른 염증인자의 변화
- 천연식물을 이용한 AT-Grow의 발모효과
- Ruolo dei neurosteroidi nella modulazione dopaminergica
- Saw Palmetto
- Scalp lesions, in images
- AB40. Sexual side effects of medical treatment of BPH
- 利用地面光達點雲建置三維房屋模型;Reconstructing 3D Building Model from Terrestrial LiDAR Point Cloud
- 5ARI and PSA: open questions
- PD23-01 INHIBITOR OF 5A-REDUCTASE TYPES II PROMOTES THE INFILTRATION OF CD8+T CELLS IN BPH TISSUES.
- PD23-06 CHANGE IN SEXUAL FUNCTION IN MEN WITH LUTS/BPH ASSOCIATED WITH LONG-TERM TREATMENT WITH DOXAZOSIN, FINASTERIDE, AND COMBINED THERAPY
- 팔정산약침이 실험적으로 유발된 전립선 비대증 Rat에 미치는 영향
- Influence of tamsulosin and finasteride on circadian rhythm and cardiac function in male elderly patients with chronic heart failure
- Experience of using of Sonirid Duo in treatment of patients with BPH
- Finasteride
- 피나스테라이드의 특성에 대한 이론적 연구
- Metabolic effects of 5α-reductase inhibition in humans
- The research of Finasteride and Tamsulosin to reduce hemorrhage during TURP
- 5α-Reductases in Human Physiology: An Unfolding Story
- Glatze in jungen Jahren könnte Risikofaktor für BPH sein
- Intervention beim PCa: leichte Pluspunkte für radikale Prostatektomie
- 1153 ERECTILE HEMODYNAMICS ASSESSMENT IN MEN WITH PERSISTENT ERECTILE DYSFUNCTION AFTER 5-ALPHA REDUCTASE INHIBITOR USE
- 1262 ONE YEAR FINASTERIDE THERAPY IN MEN WITH A SERUM PSA GREATER THAN 4 NG/ML WHO HAD UNDERGONE REPEAT BIOPSY
- Male alopecia, finasteride, and cancer risk
- Клинико-морфологическая характеристика ПЖ на фоне лечения ингибиторами 5-альфаредуктазы при ДГПЖ
- Оптимизация подходов консервативной терапии доброкачественной гиперплазии предстательной железы ингибиторами 5-альфаредуктазы. Клинико-морфологическое исследование
- ChemInform Abstract: Rα‐Reductase Inhibitors‐ — The Finasteride Story
- Les Visiteurs des malades
- UP-02.011 Biofeedback Treatment for Dysfunctional Voiding Diagnosed in Adulthood
- When two plus two must not equal four
- ChemInform Abstract: Discovery of a Novel Hybrid from Finasteride and Epristeride as 5α‐Reductase Inhibitor.